7PX5

ATAD2 in complex with 1-Methyl-2-quinolone

これはPDB形式変換不可エントリーです。

7PX5 の概要

• エントリーDOI: 10.2210/pdb7px5/pdb
• 分子名称: ATPase family AAA domain-containing protein 2, 1-METHYLQUINOLIN-2(1H)-ONE, SULFATE ION, ... (5 entities in total)
• 機能のキーワード: transcription, transcription regulation, activator, hydrolase, nucleotide-binding, fragment binding, inhibitor
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 15894.97

構造登録者

Martin, M.P.,Noble, M.E.N. (登録日: 2021-10-07, 公開日: 2022-11-02, 最終更新日: 2024-01-31)

主引用文献

Martin, M.P.,Noble, M.E.M.
Exiting the tunnel of uncertainty: crystal soak to validated hit.
Acta Crystallogr D Struct Biol, 78:1294-1302, 2022

PubMed Abstract: Crystallographic fragment screens provide an efficient and effective way to identify small-molecule ligands of a crystallized protein. Due to their low molecular weight, such hits tend to have low, often unquantifiable, affinity for their target, complicating the twin challenges of validating the hits as authentic solution-phase ligands of the target and identifying the `best' hit(s) for further elaboration. In this article, approaches that address these challenges are assessed. Using retrospective analysis of a recent ATAD2 hit-identification campaign, alongside other examples of successful fragment-screening campaigns, it is suggested that hit validation and prioritization are best achieved by a `triangulation' approach in which the results of multiple available biochemical and biophysical techniques are correlated to develop qualitative structure-activity relationships (SARs). Such qualitative SARs may indeed be the only means by which to navigate a project through the tunnel of uncertainty that prevails before on-scale biophysical, biochemical and/or biological measurements become possible.

PubMed: 36322414
DOI: 10.1107/S2059798322009986

実験手法

X-RAY DIFFRACTION (2.18 Å)